pioneer
work
schena
colleagu
publish
complet
outstand
method
molecular
technolog
schena
et
al
first
use
multiparametr
transcript
profil
technolog
rapidli
develop
toward
tool
detect
kind
biolog
target
dna
rna
protein
cell
nucleic
acid
carbohydr
etc
modif
methyl
phosphoryl
etc
within
last
year
principl
simpl
biolog
interact
molecul
eg
interact
complementari
base
nucleic
acid
interact
interact
carbohydr
lectin
repres
basic
principl
microarray
technolog
exampl
follow
basic
principl
dna
microarray
describ
detect
target
molecul
eg
mrna
genom
dna
oligonucleotid
complementari
respect
target
molecul
immobil
solid
support
like
glass
nylon
polym
silicon
order
microarray
oligonucleotid
may
correspond
open
read
frame
organ
allow
transcript
profil
sampl
interest
eg
rna
extract
label
use
nucleic
acid
polymer
enzym
eg
revers
transcriptas
polymeras
gener
cdna
fluoresc
label
nucleotid
hybrid
microarray
lead
specif
molecular
interact
locat
complementari
strand
immobil
readout
use
fluoresc
scanner
photomultipli
tube
imag
ccd
camera
give
inform
target
molecul
present
analyz
sampl
pollack
fig
next
direct
label
also
indirect
label
techniqu
use
biotinlabel
nucleotid
incorpor
pcr
und
afterward
detect
use
streptavidin
antibodi
conjug
one
first
exampl
publish
shortli
work
schena
et
al
start
commerci
nucleic
acid
microarray
affymetrix
usa
wodicka
et
al
anoth
exampl
colorimetr
technolog
use
eppendorf
microarray
biotinlabel
nucleotid
use
pcr
reaction
goldcoupl
antibodi
biotin
ad
hybrid
colorimetr
reaction
start
ad
silver
nitrat
reduc
agent
lead
silver
precipit
gold
particl
anoth
label
technolog
use
peroxidas
conjug
colorimetr
detect
rubtsova
et
al
microarray
technolog
revolution
dna
rna
research
contrast
classic
biolog
assay
microarray
enabl
parallel
analysi
sever
ten
thousand
analyt
analysi
nucleic
acid
applic
possibl
rang
focus
set
multipl
transcript
unit
transcript
profil
genom
fragment
analysi
copi
number
genet
variat
entir
genom
beyond
avail
complet
genom
sequenc
keyston
develop
use
genomewid
technolog
like
array
technolog
past
centuri
sequenc
entir
genom
major
effort
academ
commerci
research
first
sequenc
eukaryot
genom
genom
saccharomyc
cerevisia
second
complet
sequenc
genom
genom
sequenc
daunt
task
total
number
sequenc
organ
rather
small
includ
bacteria
fungu
cerevisia
invertebr
caenorhabd
elegan
drosophila
melanogast
plant
arabidopsi
thaliana
rel
small
simpl
genom
year
first
eukaryot
genom
present
first
draft
human
genom
sequenc
publish
lander
et
al
venter
et
al
human
draft
sequenc
although
landmark
still
rather
imperfect
cover
euchromat
genom
interrupt
gap
year
later
catalogu
sequenc
organ
includ
alreadi
project
includ
microbi
organ
close
vertebr
organ
complet
ongo
sequenc
project
organ
statu
sept
pruitt
et
al
major
reason
explos
genom
sequenc
due
develop
addit
revolution
technolog
begin
twentyfirst
centuri
gener
term
nextgener
sequenc
ng
marguli
et
al
refer
later
paragraph
articl
last
ncbi
updat
octob
number
public
archiv
increas
prokaryot
regist
genom
project
repres
differ
speci
assembl
genom
either
complet
draft
remaind
either
submit
sequenc
data
yet
raw
sequenc
read
upload
sequenc
read
archiv
kodama
et
al
sequenc
restrict
individu
organ
includ
also
microbi
commun
like
sampl
midocean
environment
remedi
site
human
sampl
gut
skin
grice
et
al
gill
et
al
remark
partial
genom
sequenc
even
obtain
sever
extinct
speci
includ
woolli
mammoth
neanderth
green
et
al
addit
popul
one
speci
sequenc
like
k
genom
project
microbi
pathogen
timm
et
al
genom
project
human
genom
project
consortium
et
al
enabl
complet
new
approach
medic
research
diagnost
includ
develop
diagnost
microarray
parallel
complet
first
genom
sequenc
dna
microarray
technolog
develop
mention
pioneer
experi
focus
express
profil
use
model
organ
like
cerevisia
monitor
chang
transcript
activ
everi
known
annot
gene
singl
experi
cerevisia
first
genomewid
transcript
analys
inde
appear
shortli
complet
genom
sequenc
derisi
et
al
hauser
et
al
wodicka
et
al
nucleic
acid
level
set
start
genomewid
analys
organ
base
knowledg
genom
cerevisia
one
major
model
organ
key
develop
biochem
bioinformat
method
necessari
transcript
profil
today
thousand
transcript
profil
gener
almost
sequenc
speci
besid
knowledg
genom
way
gener
analyz
data
prerequisit
transcriptom
overview
data
analysi
method
howev
beyond
scope
chapter
sever
book
microarray
technolog
data
analysi
written
introduc
perfectli
topic
bremer
et
al
dufva
microarray
fabric
shortli
introduc
discuss
follow
detail
three
main
way
manufactur
dna
microarray
lightdirect
synthesi
photolithographi
piezoelectr
inkjet
print
robot
spot
hugh
et
al
tan
et
al
dufva
photolithographi
premad
mask
digit
micromirror
devic
use
premad
mask
use
affymetrix
platform
everi
nucleotid
nt
ad
grow
strand
solid
support
mask
cover
region
microarray
base
addit
take
place
appli
previou
nucleotid
block
group
remov
photosensit
reaction
uv
lightinduc
deprotect
extens
one
nucleotid
take
place
technolog
rather
expens
due
mask
cost
everi
array
design
need
set
mask
usual
probe
nt
length
probe
per
gene
synthes
anoth
photolithographi
technolog
use
nimblegen
singlenucleotid
extens
perform
lightmedi
inactiv
photolabil
protect
group
afterward
base
addit
similar
affymetrix
technolog
howev
nimblegen
use
micromirror
devic
lead
light
need
inactiv
protect
group
everi
desir
spot
microarray
therefor
need
mask
anymor
make
technolog
much
cheaper
anoth
technolog
make
microarray
piezoelectr
inkjet
print
technolog
also
call
hp
technolog
deduc
hp
print
technolog
agil
sure
print
technolog
exampl
industri
platform
produc
cdna
oligonucleotid
microarray
cdna
spot
directli
oligonucleotid
synthes
basebybas
repetit
print
layer
use
standard
phosphoramidit
chemistri
http
wide
use
technolog
microarray
product
especi
field
research
institut
univers
robot
spot
technolog
eg
protein
pcr
product
oligonucleotid
spot
solid
glass
support
use
split
solid
pin
use
split
pin
dna
fed
capillari
forc
deposit
defin
locat
microarray
use
robot
technolog
usual
pcr
product
kb
oligonucleotid
nt
length
print
technolog
afford
therefor
often
use
individu
research
lab
next
classic
technolog
also
semiconductorbas
system
develop
exampl
combimatrix
use
system
product
microarray
thousand
platinum
microelectrod
address
simultan
synthes
individu
oligonucleotid
digit
control
synthesi
activ
microelectrod
lead
product
acid
electrochem
reaction
lead
deprotect
grow
oligonucleotid
strand
activ
next
synthesi
step
possibl
individu
address
thousand
microelectrod
parallel
allow
comfort
product
individu
microarray
ghindili
et
al
oligo
synthes
parallel
mer
natur
dna
use
probe
captur
molecul
dna
microarray
system
order
reduc
crossreact
increas
interact
target
sampl
appli
nonnatur
variant
use
captur
molecul
includ
ldna
hauser
et
al
pna
variant
sforza
et
al
ldna
probe
great
advantag
interact
exact
kinet
antiparallel
ldna
strand
like
ddna
duplex
thu
knowledg
gain
ddnamicroarray
use
ldna
equival
bind
target
like
rna
dna
even
peptidesepitop
chemic
molecul
socal
zipcod
array
use
probe
use
zipcod
array
fusion
target
bound
solut
use
eg
natur
ddna
oligom
complementari
target
dnarna
fuse
ldna
ldna
oligom
address
immobil
complementari
ldna
oligonucleotid
microarray
surfac
allow
liter
backgroundfre
hybrid
array
howev
price
synthes
ldna
oligom
rather
high
hamper
develop
pdna
synthet
nucleic
acid
analogu
base
pseudopeptid
backbon
instead
phosphodiest
backbon
show
excel
sequencespecif
recognit
properti
less
suscept
chang
ionic
strength
sinc
charg
repuls
neg
charg
backbon
present
dna
duplex
miss
result
higher
affin
shown
higher
melt
curv
pnadna
pnarna
duplex
compar
natur
counterpart
brandt
hoheisel
jacob
et
al
sforza
et
al
next
planar
array
system
beadbas
system
develop
like
random
bead
array
suspens
array
bead
mark
differ
amount
fluoresc
dye
anoth
barcod
technolog
individu
identifi
coupl
eg
oligonucleotid
bead
specif
bind
event
detect
exampl
illumina
develop
bead
array
technolog
use
either
planar
silicon
slide
fiberopt
bundl
silicon
wafer
optic
fiber
etch
individu
bead
fit
result
three
microns
well
bind
event
bead
subsequ
identifi
technolog
use
fluoresc
label
primer
http
wwwncbinlmnihgovprojectsgenomeprobedoctechbeadarrayshtml
similar
suspens
array
also
use
optic
differenti
bead
coupl
interest
biomolecul
eg
oligonucleotid
antibodi
hybrid
reaction
fluoresc
label
substrat
take
place
solut
subsequ
fac
fluorescenceactiv
cell
sort
sort
process
allow
identif
bind
process
exampl
luminex
xmap
technolog
http
wwwluminexcorpcomtechnologiessciencexmaptechnolog
dna
microarray
wide
use
research
tool
lab
accord
huge
amount
literatur
publish
field
microarray
address
specif
target
like
protein
carbohydr
tissu
cell
develop
well
review
mani
review
exist
deal
topic
like
wholegenom
express
analysi
review
pubm
search
string
microarray
express
analysi
cancer
research
chibon
daigo
et
al
ho
et
al
satootsubo
et
al
tiwari
molecular
karyotyp
dhillon
et
al
chromosom
microarray
analysi
bradi
vermeesch
phylogeneticsmicrobiom
nikolaki
tsiami
gene
regul
via
chipchip
falk
powel
et
al
dna
microarray
use
studi
heart
diseas
phan
et
al
aspect
dermatolog
villasenorpark
ortegaloayza
mental
disord
like
autism
carter
scherer
mani
other
detail
overview
focus
applic
clinic
microbiolog
given
miller
et
al
miller
tang
follow
section
detail
overview
select
researchdriven
microarray
given
past
centuri
brought
avail
vaccin
antibiot
lead
dramat
fall
mortal
caus
infecti
diseas
nevertheless
today
nearli
annual
death
worldwid
directli
relat
pathogen
moren
et
al
attribut
appear
new
diseas
like
hiv
sar
west
nile
viru
recent
ebola
outbreak
also
increas
resist
antibiot
pathogen
thought
defeat
like
mycobacterium
tuberculosi
staphylococcu
enterococcu
strain
addit
progress
medic
care
result
larg
proport
temporarili
lifelong
immunedefici
patient
consequ
increas
opportunist
infect
often
result
sepsi
requir
fast
accur
diagnosi
save
patient
live
approxim
speci
identifi
known
pathogen
human
includ
bacteria
fungi
cleaveland
et
al
indic
multiparametr
problem
identif
diseasecaus
pathogen
dna
microarray
emerg
viabl
platform
detect
pathogen
organ
microbi
detect
array
regard
cost
applic
rang
low
cost
narrowli
focus
assay
like
multiplex
pcr
expens
broadspectrum
technolog
like
highthroughput
sequenc
pathogen
detect
array
use
primarili
research
context
howev
sever
group
develop
array
clinic
diagnost
food
safeti
test
environment
monitor
biodefens
statist
algorithm
enabl
data
analysi
provid
easili
interpret
result
absolut
requir
applic
detect
array
one
first
microarray
design
wide
rang
pathogen
virochip
wang
et
al
updat
version
publish
shortli
thereaft
wang
et
al
array
fabric
robot
spot
oligo
contain
initi
probe
deriv
viral
genom
avail
time
sinc
probe
design
conserv
sequenc
common
taxonom
famili
could
use
identifi
novel
virus
within
famili
virochip
therefor
could
contribut
character
novel
coronaviru
respons
sar
outbreak
ksiazek
et
al
also
today
virochip
still
use
clinic
studi
util
detect
virus
acut
respiratori
tract
infect
children
could
shown
clinic
studi
children
show
superior
perform
regard
sensit
specif
profil
expand
spectrum
detect
virus
compar
serolog
pcrbase
detect
method
chiu
et
al
latest
version
array
base
agil
inkjet
platform
chen
et
al
one
comprehens
array
describ
garden
et
al
gardner
et
al
base
nimblegen
technolog
platform
report
panmicrobi
detect
array
mda
detect
known
virus
includ
phage
bacteria
plasmid
time
describ
includ
novel
statist
analysi
method
identifi
mixtur
organ
complex
sampl
hybrid
array
array
famili
specif
probe
select
sequenc
viral
bacteri
complet
genom
probe
array
design
toler
sequenc
variat
allow
detect
diverg
speci
provid
homolog
sequenc
organ
given
describ
virochip
use
comprehens
chip
blind
test
spike
sampl
clinic
fecal
serum
respiratori
sampl
chip
abl
correctli
identifi
multipl
speci
strain
confirm
pcr
addit
mani
differ
array
focus
defin
pathogen
famili
pathogen
well
resist
pattern
describ
detect
fungal
infect
especi
intens
care
unit
hospit
emerg
major
caus
morbid
mortal
immunecompromis
patient
diagnost
microarray
rapid
simultan
identif
common
pathogen
candida
aspergillu
speci
develop
oligonucleotid
probe
design
base
sequenc
variat
intern
transcrib
spacer
region
use
univers
pcr
amplifi
fungal
target
region
array
valid
use
clinic
isol
blind
sampl
leinberg
et
al
array
detect
resist
determin
like
lactamas
establish
well
exampl
leinberg
et
al
describ
extendedspectrum
betalactamas
detect
array
abl
detect
resist
mechan
base
tem
shv
ctxm
type
confer
resist
betalactam
antibiot
gramneg
bacteria
leinberg
et
al
activ
enzym
betalactam
antibiot
resist
inhibitor
influenc
genet
variat
singlenucleotid
level
array
describ
consist
probe
cover
mutat
respons
amino
acid
substitut
valid
dna
microarray
demonstr
blind
clinic
isol
collect
clinic
routin
chip
character
success
regard
resolut
correl
abil
resolv
mix
genotyp
also
resist
mechan
emerg
pathogen
like
acinetobact
baumannii
detect
use
array
dalli
et
al
develop
microarray
use
detect
target
sequenc
associ
antibiot
resist
within
h
bacteri
cultur
dalli
et
al
array
valid
multidrugresist
strain
baumannii
blind
prospect
studi
compar
result
determin
system
base
phenotyp
suscept
array
abl
detect
relev
resist
determin
baumannii
parallel
thu
enabl
fast
result
order
initi
adequ
antiinfect
therapi
critic
ill
patient
use
epidemiolog
surveil
transcript
profil
rapidli
expand
research
type
human
cancer
start
alreadi
initi
draft
human
genom
publish
breast
cancer
one
intens
studi
human
cancer
regard
microarraybas
gene
express
profil
cancer
classif
prognosi
predict
one
reason
besid
high
frequenc
breast
cancer
popul
observ
although
approxim
patient
earli
breast
cancer
receiv
form
chemotherapi
minor
benefit
schmidt
et
al
therefor
reliabl
prognost
predict
marker
need
guid
select
appropri
adjuv
therapi
individu
patient
breast
cancer
microarray
actual
contribut
significantli
chang
understand
breast
cancer
heterogen
group
complex
tumor
instead
singl
group
pioneer
work
perou
colleagu
rediscov
larg
heterogen
breast
cancer
tumor
molecular
level
perou
et
al
demonstr
erposit
erneg
tumor
cell
fundament
differ
express
profil
led
suggest
use
microarraybas
multigen
prognost
classifi
known
gene
signatur
diagnost
signatur
prognosticpredict
marker
panel
therapi
decis
last
decad
sever
group
embark
identif
gene
signatur
breast
cancer
diagnost
goal
predict
chemotherapi
omit
earlystag
breast
cancer
select
appropri
treatment
one
first
prognost
signatur
consist
gene
enabl
identif
good
prognosi
patient
minim
risk
develop
metastas
within
next
year
van
veer
et
al
signatur
valid
sever
clinic
trial
gener
use
fresh
biopsi
tissu
prepar
transcript
profil
last
year
commerci
avail
via
agendia
use
microarray
base
agil
technolog
guid
therapi
earlystag
breast
cancer
exner
et
al
parallel
gene
signatur
consist
diagnost
gene
control
establish
base
qrtpcr
oncotyp
dx
paik
et
al
assay
also
underw
sever
clinic
trial
recent
posit
evalu
econom
impact
patient
manag
nerich
et
al
sever
assay
develop
nice
review
colombo
et
al
zanotti
et
al
colombo
et
al
zanotti
et
al
summari
show
within
last
year
develop
microarray
enabl
success
setup
multigen
assay
design
support
physician
patient
clinic
decisionmak
earlystag
breast
cancer
noncod
rna
especi
microrna
describ
last
decad
key
development
regul
bushati
cohen
therefor
consider
effort
made
unravel
function
mirna
use
diagnost
marker
especi
cancer
jansson
lund
zhang
et
al
also
diseas
includ
neurodegen
diseas
gandhi
et
al
cardiovascular
diseas
elli
et
al
infecti
diseas
shrivastava
et
al
detect
small
noncod
rna
like
microrna
challeng
sinc
short
matur
form
contain
neither
cap
poli
tail
natur
addit
matur
form
exist
priform
preform
process
transport
nucleu
complex
sequenc
event
review
nice
bartel
bartel
sever
system
describ
enabl
microrna
detect
microarray
platform
exampl
agil
develop
platform
includ
special
label
technolog
enabl
detect
mirna
tissu
formalinfix
biopsi
materi
andrad
fulmersmentek
profil
differ
mirna
matur
level
parallel
import
comprehens
cancer
classif
hara
et
al
therefor
desir
distinguish
matur
pri
preform
sinc
matur
mirna
also
part
preform
avail
microarray
system
gener
abl
distinguish
prematur
matur
mirna
without
costli
size
exclus
approxim
data
analysi
howev
use
zipcod
array
system
togeth
defin
label
approach
system
enabl
distinct
premirna
matur
form
describ
recent
weishaupt
et
al
weishaupt
et
al
label
form
mirna
poli
tail
distinguish
mirna
contain
still
precursor
sequenc
matur
mirna
contain
poli
tail
direct
proxim
matur
sequenc
done
use
primer
extens
reaction
combin
two
distinct
zipcod
primer
hybrid
matur
mirna
target
specif
complementari
zip
array
two
zipcod
primer
use
two
distinct
label
reaction
contain
unlabel
dttp
togeth
label
reaction
allow
detect
matur
form
unlabel
datp
dctp
dgtp
dttp
togeth
label
reaction
detect
precursor
form
shown
fig
combin
label
reaction
one
array
identifi
via
specif
complementari
zip
code
amount
prematur
matur
mirna
possibl
precursor
mirna
speci
abl
carri
label
datp
sinc
poli
tail
directli
follow
matur
form
allow
integr
datp
matur
form
label
reaction
see
fig
matur
mirna
speci
abl
contain
via
poli
tail
label
reaction
perform
separ
achiev
mix
one
array
readout
use
set
welldefin
evalu
zipcod
primer
quantit
readout
could
demonstr
sever
manual
step
diagnost
dna
microarray
sampl
result
like
nucleic
acid
extract
amplif
revers
transcript
label
hybrid
data
readout
data
analysi
step
potenti
risk
contamin
mistak
one
possibl
overcom
limit
autom
use
socal
micro
total
analysi
system
labonachip
devic
loc
allow
complet
sampl
prepar
analysi
readout
singl
close
devic
microfluid
devic
nano
even
picolit
volum
transport
micrometers
channel
filter
mix
process
detect
fluid
transport
often
pressuredriven
altern
also
induc
electroosmot
flow
capillari
forc
complet
autom
harbor
sever
advantag
like
get
smaller
sampl
volum
diminish
contamin
risk
faster
assay
process
due
small
diffus
way
effici
thermodynam
favor
surfacetovolum
ratio
well
multiplex
highthroughput
capabl
implement
complet
process
sampl
result
loc
devic
howev
complex
first
one
implement
singl
function
unit
end
combin
run
concert
one
complet
process
challeng
next
other
choic
materi
compat
assay
step
assembl
process
modif
biolog
assay
maxim
compat
mani
research
institut
work
develop
loc
devic
review
howev
beyond
scope
review
focu
lie
arraybas
loc
devic
found
may
find
way
clinic
routin
laboratori
sever
compani
work
loc
devic
nucleic
acid
analyt
use
dna
microarray
detect
system
like
cureti
compani
holzgerlingen
germani
use
patent
special
array
technolog
loc
devic
cell
lysi
done
separ
process
unit
step
purif
amplif
detect
perform
singl
cartridg
cureti
technolog
use
diagnos
infect
cecertifi
cartridg
offer
detect
pathogen
resist
marker
pneumonia
implant
tissu
infect
iti
fda
clearanc
aspir
anoth
complet
solut
arraybas
detect
develop
nanospher
verigen
system
allow
simpl
test
nucleic
acid
protein
singl
platform
http
wwwnanosphereustechnolog
detect
dna
rna
target
nanoparticl
probe
technolog
use
autom
nucleic
acid
extract
pcr
amplif
clinic
sampl
take
place
processor
sp
elut
nucleic
acid
transfer
automat
verigen
test
cartridg
hybrid
target
dna
captur
oligonucleotid
microarray
detect
realiz
specif
mediat
oligonucleotid
gold
nanoparticl
probe
signal
amplif
hybrid
probe
done
via
silver
stain
process
autom
qualit
analysi
result
perform
verigen
reader
diseas
like
bacteri
infect
cardiac
test
address
rheonix
http
wwwrheonixcomtechnologytechnologyoverviewphp
develop
encompass
platform
dispos
card
onboard
reagent
lowdens
microarray
qpcrbase
detect
system
heart
system
compani
state
everi
userdesign
futur
fdaclear
test
run
card
due
high
flexibl
system
product
develop
program
infecti
diseas
pharmacogenom
environment
applic
progress
next
dna
microarraybas
detect
loc
devic
one
find
quantit
realtim
pcr
phmediat
detect
ng
technolog
readout
strategi
cepheid
http
wwwcepheidcomu
develop
integr
benchtop
analyz
genexpert
detect
sever
pathogen
resist
marker
microfluid
cartridg
ultrason
lysi
multiplex
rapid
realtim
pcr
techniqu
realiz
compani
cecertifi
cartridg
detect
eg
clostridium
difficil
c
difficil
methicillinresist
staphylococcu
aureu
mrsa
noroviru
fdaapprov
test
e
g
mrsa
tuberculosi
focu
diagnost
http
develop
integr
cycler
diskbas
qpcrbase
analyt
system
sampl
run
parallel
assay
offer
detect
viralcaus
infect
like
dengu
fever
influenza
infecti
mononucleosi
viru
detect
bacteria
like
bordetella
speci
c
difficil
idaho
technolog
biofir
biomerieux
develop
product
seri
base
poritz
et
al
novel
diagnost
platform
combin
autom
sampl
prepar
nucleic
acid
extract
pcrbase
detect
multipl
target
singl
unprocess
sampl
h
combin
nest
multiplex
pcr
refer
nest
multiplex
nmpcr
togeth
dna
melt
curv
analysi
detect
distinguish
multipl
pathogen
simultan
filmarray
filmarray
respiratori
panel
rp
pouch
sinc
receiv
fda
clearanc
use
vitro
diagnost
ivd
devic
advanc
liquid
logic
http
wwwliquidlogiccomtechnolog
acquir
illumina
juli
digit
microfluid
technolog
base
use
electrowet
precis
manipul
droplet
surfac
electrowet
voltag
appli
droplet
insul
electrod
caus
droplet
spread
surfac
allow
precis
manipul
droplet
within
seal
microfluid
loc
illumina
mainli
interest
deliv
simplest
effici
sampletoansw
nextgener
sequenc
ng
workflow
press
releas
dna
electron
http
dnaecouktechnologyoverview
develop
electronicbas
microchip
solut
dna
rna
detect
ionsensit
field
effect
transistor
isfet
use
genotyp
semiconductorbas
sequenc
whenev
dna
rna
amplifi
h
ion
releas
detect
isfet
therefor
specif
hybrid
event
detect
address
healthcar
applic
field
person
medicin
infect
screen
anoth
sensor
technolog
develop
genefluid
technolog
enabl
quantif
nucleic
acid
protein
singl
platform
electrochem
detect
high
sensit
even
unamplifi
unpurifi
biolog
sampl
advertis
result
deliv
within
h
sensor
surfac
function
antibodi
dna
bind
event
wash
step
secondari
antibodi
hrp
report
enzym
bind
appli
signal
occur
enzymat
convers
hrp
substrat
proport
analyt
concentr
http
wwwgenefluidicscomtechnolog
handylab
acquir
bd
develop
dispos
cartridg
onboard
dri
reagent
patent
realtim
microfluid
pcr
technolog
cartridg
could
run
benchtop
instrument
integr
heat
mechan
valv
fluid
control
fluoresc
detect
fdaapprov
test
avail
mrsa
c
difficil
group
b
streptococci
test
one
test
vancomycinresist
enterococci
approv
use
europ
anoth
interest
complet
differ
system
labinatub
system
system
iquum
http
wwwiquumcomproductstechnologyshtml
assay
reagent
prepack
tube
segment
separ
peelabl
seal
liat
liat
compress
sampl
process
actuat
liat
analyz
reagent
select
releas
tube
segment
sampl
move
one
segment
anoth
reaction
condit
control
start
varieti
sampl
matric
includ
whole
blood
plasma
urin
swab
sampl
requir
assay
process
includ
reagent
prepar
nucleic
acid
purif
amplif
realtim
detect
perform
analyz
h
depend
assay
rapid
pcr
amplif
realtim
detect
integr
product
influenza
assay
research
use
fulli
autom
sampletoresult
detect
viral
rna
min
receiv
fda
emerg
use
author
sinc
expir
influenza
ab
assay
ivd
product
assay
hiv
cmv
influenza
subtyp
dengu
product
pipelin
year
sanger
sequenc
within
year
three
differ
novel
commerci
avail
sequenc
approach
introduc
pyrosequenc
technolog
life
scienc
later
acquir
roch
ligationbas
shortread
sequenc
technolog
appli
biosystem
solid
solexa
shortread
sequenc
system
use
bridg
amplif
sequenc
revers
dye
termin
later
acquir
illumina
discuss
impress
technolog
approach
sum
nextgener
sequenc
ng
approach
scope
review
nice
overview
given
e
g
voelkerd
et
al
sinc
sever
highthroughput
sequenc
technolog
develop
one
exampl
semiconductorbas
nonopt
sequenc
system
ion
torrentlif
technolog
phshift
occur
incorpor
desoxynucleotid
grow
strand
monitor
ionsensit
field
effect
transistor
rothberg
et
al
today
even
singl
molecul
sequenc
possibl
pacif
bioscienc
http
wwwpacificbiosciencescom
technolog
develop
could
allow
sequenc
whole
genom
nanopor
within
shortest
time
announc
e
g
oxford
nanopor
technolog
http
wwwnanoporetechcom
nearli
everi
dnabas
array
platform
mirror
sequencingbas
technolog
procedur
enorm
highthroughput
capabl
ng
technolog
wholegenom
approach
afford
perform
includ
transcript
analysi
rnaseq
review
mutz
et
al
target
genom
even
wholegenom
resequenc
ng
et
al
tsuji
comparison
genom
map
dnabind
protein
chromatin
analysi
epigenet
review
capel
berger
mensaert
et
al
methyl
analysi
review
olkhovmitsel
bapat
metagenom
review
cox
et
al
kim
et
al
miller
et
al
interestingli
combin
microarray
nextgener
sequenc
establish
order
focu
relev
part
human
genom
snp
detect
exom
sequenc
perform
instead
use
genotyp
array
exom
sequenc
code
sequenc
human
genom
sequenc
identifi
variant
individu
approxim
exon
compris
million
base
pair
report
constitut
human
genom
director
abo
focus
mutat
exon
much
like
caus
effect
sequenc
effort
reduc
two
order
magnitud
exon
enrich
effici
sever
enrich
method
describ
lin
et
al
one
use
dna
microarray
contain
complementari
sequenc
exon
exampl
nimbl
gene
develop
socal
sequenc
captur
human
exom
array
enrich
code
exon
choi
et
al
exom
sequenc
use
approach
identifi
unknown
causal
gene
rare
mendelian
disord
ng
et
al
advantag
sequenc
technolog
requir
preexist
get
everi
mutat
snp
repres
array
challeng
case
specif
sequenc
enrich
gener
knowhow
effect
individu
snp
detect
combin
human
wellb
first
compani
make
exom
sequenc
avail
diagnost
purpos
ambri
introduc
clinic
diagnost
compani
also
offer
highli
special
genet
test
http
wwwambrygencomclinicaldiagnost
focus
singl
gene
diagnost
today
sanger
sequenc
use
identif
rare
variant
ng
capac
replac
sanger
sequenc
target
genom
ng
sikkemaraddatz
et
al
use
approach
subset
gene
known
import
involv
special
diseas
sequenc
sikkemaraddatz
et
al
construct
target
enrich
kit
includ
gene
associ
hereditari
cardiomyopathi
demonstr
target
ng
diseasespecif
subset
gene
equal
qualiti
sanger
sequenc
use
illumina
miseq
sequenc
sikkemaraddatz
et
al
state
therefor
reliabl
implement
standalon
diagnost
test
illumina
offer
miseqdx
cystic
fibrosi
cf
assay
detect
clinic
relev
cftr
cftransmembran
conduct
regul
variant
miseqdx
cystic
fibrosi
clinic
sequenc
assay
accur
captur
variant
proteincod
region
intronexon
boundari
cftr
grosu
et
al
first
fdaclear
ngsbase
assay
kit
vitro
diagnost
use
miseqdx
instrument
http
wwwilluminacomclinicaldiagnosticsilmn
current
ng
technolog
get
cheaper
easier
handl
also
might
molecular
assay
choic
futur
clinic
clinic
diagnost
requir
easytohandl
experiment
procedur
robust
accuraci
sensit
compar
lower
cost
compar
exist
diagnost
approach
although
recent
develop
ng
led
small
instrument
allow
flexibl
throughput
short
run
time
current
drawback
ng
approach
high
invest
run
cost
elabor
librari
prepar
complex
data
analysi
detach
shortcom
possibl
ng
novel
diagnost
scale
thinkabl
diagnost
cancer
mitochondri
disord
hereditari
diseas
assay
time
gener
critic
also
assay
clinic
microbiolog
like
detect
mrsa
sepsi
caus
organ
within
scientif
commun
workshop
symposium
held
everywher
deal
topic
ng
validli
use
clinic
diagnost
fda
also
look
deeper
subject
perform
public
workshop
focu
evalu
use
ng
technolog
clinic
diagnost
eg
ultra
high
throughput
sequenc
clinic
diagnost
assess
analyt
valid
report
public
meet
june
http
public
regulatori
scienc
high
throughput
sequenc
devic
microbi
identif
detect
antimicrobi
resist
marker
april
http
activ
indic
strong
competit
new
technolog
field
diagnost
microarray
develop
use
detect
analyz
wide
rang
target
molecul
great
portfolio
excel
research
done
field
deal
molecular
interact
also
data
analysi
autom
assay
step
although
develop
nearli
year
ago
technolog
realli
find
way
routin
clinic
laboratori
diagnost
array
use
applic
describ
main
reason
high
complex
technolog
miss
robust
accuraci
sensit
discuss
microarray
procedur
requir
mani
complex
often
manual
step
prone
error
need
skill
staff
expens
equip
process
one
way
overcom
shortcom
might
autom
process
step
use
loc
devic
allow
conveni
reproduc
process
patient
sampl
minim
risk
handl
error
contamin
diagnost
assay
begin
sampl
prepar
includ
data
readout
process
easili
perform
use
system
might
promis
path
microarray
find
way
clinic
laboratori
diagnost
larger
scale
nevertheless
ng
high
potenti
revolution
diagnost
market
within
next
decad
open
technolog
clearli
compet
arraybas
system
get
screen
cheaper
comfort
sequenc
system
get
includ
data
storag
analysi
interpret
sooner
replac
arraybas
system
howev
detect
exactli
defin
genet
disord
clinic
microbiolog
detect
limit
set
molecular
marker
eg
transcript
level
cancer
diagnost
array
technolog
still
forese
futur
valuabl
diagnost
tool
aid
therapi
